[Tecfidera® (delayed-release dimethylfumarate) in the treatment of relapsing-remitting multiple sclerosis]. Farmeconomia. Health Economics and Therapeutic Pathways, [S. l.], v. 18, n. 2S, 2017. DOI: 10.7175/fe.v18i2s.1320. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/1320. Acesso em: 28 dec. 2025.